• Global Benzhexol Hydrochloride drug market size was valued at USD 59.2 million in 2024 and is projected to grow from USD 61.3 million in 2025 to USD 75.8 million by 2032, exhibiting a CAGR of 3.4% during the forecast period.
Email: help@intelmarketresearch.com +91 9169164321
• Benzhexol Hydrochloride, also known as Trihexyphenidyl, is an anticholinergic medication primarily used to treat Parkinson's disease symptoms and drug-induced extrapyramidal disorders. As a central nervous system agent, it works by blocking acetylcholine receptors to restore neurotransmitter balance disrupted in Parkinson's patients. The drug effectively manages motor symptoms including tremors, muscle rigidity, and involuntarymovementsthroughitsselectiveantimuscarinicaction.
Email: help@intelmarketresearch.com +91 9169164321
•Oral Solutions
•Tablets
•Injectable Formulations
By Applications
• Parkinson’s Disease
• Drug-Induced Extrapyramidal Symptoms
• Other Neurological Disorders
Email:
•Pfizer (U.S.)
•Kangpu Pharma (China)
•TASLY DIYI Pharma (China)
•Zhongnan Pharma (China)
•Sun Pharmaceutical (India)
•Biogalenic (Netherlands)
•Eisai Co Ltd (Japan)
Email: help@intelmarketresearch.com +91 9169164321
